Results 11 to 20 of about 3,280,705 (273)

The Addiction Psychiatrist as Dual Diagnosis Physician: A Profession in Great Need and Greatly Needed [PDF]

, 2013
Addiction is the number one cause of premature illness and death in the U.S., especially among people with mental illness. Yet American medicine lacks sufficient workforce capacity, expertise, training, infrastructure, and research to support treatment ...
Chambers, R. Andrew
core   +1 more source

Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial

BMC Research Notes, 2018
Objective Offering a financial incentive (‘Money for Medication’) is effective in improving adherence to treatment with depot antipsychotic medications.
Ernst L. Noordraven, André I. Wierdsma, Peter Blanken, Anthony F. T. Bloemendaal, Cornelis L. Mulder   +4 more
doaj   +1 more source

Toward the Identification of a Specific Psychopathology of Substance Use Disorders

Frontiers in Psychiatry, 2017
Addiction is a mental illness in which psychiatric conditions imply a prominent burden. Psychopathological symptoms in substance use disorder (SUD) patients are usually viewed as being assignable to the sphere of a personality trait or of comorbidity ...
Angelo G. I. Maremmani, Angelo G. I. Maremmani, Angelo G. I. Maremmani, Pier Paolo Pani, Luca Rovai, Luca Rovai, Silvia Bacciardi, Icro Maremmani, Icro Maremmani, Icro Maremmani   +9 more
doaj   +1 more source

Investigating the sequential patterns of methamphetamine use initiation in Iran

Substance Abuse Treatment, Prevention, and Policy, 2020
Background Methamphetamine (MA) remains one of the most commonly used amphetamine-type stimulants, accounting for the second most widely-used substance after marijuana. Due to increased use of MA, a wide variety of research has focused on the patterns of
Ebrahim Moghimi Sarani, Jamshid Ahmadi, Bahare Oji, Motahareh Mahi-Birjand, Nader Bagheri, Amir Bazrafshan, Marie Dehghan Manshadi, Sajad Yaghoubi, Asiyeh Dezhkam, Mehrdad Khatami, Meghdad Abdollahpour-Alitappeh   +10 more
doaj   +1 more source

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

Drugs - Real World Outcomes, 2020
Aim To evaluate the efficacy and impact of long-acting injectable (LAI) aripiprazole in patients with schizophrenia with a coexisting substance use disorder (SUD). Patients and methods A multicenter, observational, descriptive and retrospective study was
Nestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, Jose Martinez-Raga, Carlos Parro-Torres, Julia Cambra Almerge, Lara Grau-López, Mario De Matteis, Francisco Arias   +8 more
doaj   +1 more source

Integrating sports psychiatry in the interdisciplinary care of elite sports teams A conceptual model

Sports Psychiatry, 2023
: Introduction: Sports psychiatry is a developing field whose focus is the diagnosis, treatment, and management of mental illness in sports team members. Participation in elite sports can compromise mental health as psychiatric symptoms and disorders are
Armaan Zaré, Todd Stull
doaj   +1 more source

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study

Drugs - Real World Outcomes, 2020
A randomized, 1-year follow-up study comparing LAI aripiprazole with LAI paliperidone in patients with psychosis, mostly schizophrenia, and SUD reported a large effect of the change from baseline in the CGI severity score, from 5.9 to 2.4 for LAI ...
Nestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, Jose Martinez-Raga, Carlos Parro-Torres, Julia Cambra Almerge, Lara Grau-López, Mario De Matteis, Francisco Arias   +8 more
doaj   +1 more source

Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment

Frontiers in Psychiatry, 2017
Patients with alcohol-use disorders (AUDs) have a high prevalence of anxiety disorders (AnxDs). “Co-occurring disorders” refers to the coexistence of an AUD and/or drug related disorders with another non-addictive psychiatric disorder.
Carmen Gimeno, Carmen Gimeno, Marisa Luisa Dorado, Marisa Luisa Dorado, Carlos Roncero, Carlos Roncero, Nestor Szerman, Nestor Szerman, Pablo Vega, Pablo Vega, Vicent Balanzá-Martínez, F. Javier Alvarez, F. Javier Alvarez, F. Javier Alvarez   +13 more
doaj   +1 more source

Self-injurious behaviour in patients with bipolar disorder and attention deficit hyperactivity disorder after central stimulant start– a retrospective study based on the lisie cohort

European Psychiatry, 2021
Introduction Currently, our understanding remains limited of how co-occurring bipolar disorder and attention deficit hyperactivity disorder (ADHD) should be treated.
L. Öhlund, M. Ott, R. Lundqvist, M. Sandlund, E. Salander Renberg, U. Werneke   +5 more
doaj   +1 more source

Irony, deception and theory of mind in people with intellectual disabilities and dual diagnoses [PDF]

Vojnosanitetski Pregled, 2020
Background/Aim. The ability to comprehend and produce irony and deception is rarely explored in people with intellectual disability (ID) or dual diagnoses (DD). The ability to understand irony and deception appears to be related to many cognitive skills,
Đorđević Mirjana, Glumbić Nenad, Brojčin Branislav   +2 more
doaj   +1 more source